Atlas Trials

IFN-beta 1b and Remdesivir for COVID19

Clinical trial NCT04647695 · UNKNOWN

Trial details

NCT number
NCT04647695
Sponsor
The University of Hong Kong
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Covid19
Start date
2020-11-20
Primary completion
2021-07-31
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.